22 results
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
11 Apr 22
Eton Pharmaceuticals Appoints James Gruber as Chief Financial Officer
4:29pm
accounting activities for the company during its rapid growth. During Mr. Gruber’s tenure at Horizon, the company closed and integrated multiple
8-K
EX-99.1
zcr 6mjb8a4177od
31 Aug 20
Eton Pharmaceuticals Announces Appointment of Ingrid Hoos as Senior Vice President of Scientific Affairs
9:25am
DEF 14A
bp68kgia3c1q
26 Apr 19
Definitive proxy
4:34pm
8-K
EX-3.2
2hsdrcq0qwhh
20 Nov 18
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
uthg40sepsztkm4pvo4
13 Nov 18
Prospectus supplement with pricing info
5:10pm
S-1/A
EX-3.4
715qaoxf
25 Sep 18
IPO registration (amended)
12:00am
S-1/A
4vei1a0i7
25 Sep 18
IPO registration (amended)
12:00am
S-1
bnwh 58bc
10 Aug 18
IPO registration
3:20pm
S-1
EX-3.2
xjgkth9no7i1xwd22p
10 Aug 18
IPO registration
3:20pm